Cancer

Weekly Byte

Abstract: “BACKGROUND Blockade of programmed death 1 (PD-1), an inhibitory receptor expressed by T cells, can overcome immune resistance. We assessed the antitumor activity and...

Weekly Byte

[Authors' affiliations: 95 institutions worldwide]

Weekly Byte

Abstract: “To characterize somatic alterations in colorectal carcinoma, we conducted a genome-scale analysis of 276 samples, analysing exome sequence, DNA copy number, promoter methylation and...

Weekly Byte

Abstract: “BACKGROUND Enzalutamide (formerly called MDV3100) targets multiple steps in the androgen-receptor-signaling pathway, the major driver of prostate-cancer growth. We aimed to evaluate...

REUTERS/Aly Song
Sci-Bytes

Close examination of the cell and molecular biology of cancer has yielded a raft of new compounds to supplement or replace long-established approaches via some combination of surgery, radiotherapy...

Sci-Bytes

In 1996 when chemist Chad Mirkin witnessed a solution of DNA-assembled nanoparticles change from blue to red as it was heated, he knew they had invented the enabling technology for a whole new...

Sci-Bytes

The year 2007 saw the launch of a new Springer periodical, the Journal of Cancer Survivorship. A generation ago, perhaps, few would have seen the need for such a publication. In the...

Sci-Bytes

Time was when the phrase “personalized medicine” would have referred to something like the provision of medical care by a family doctor on a one-to-one basis, but for several years now indexers...

doctor consulting with patient
Sci-Bytes

More than 17,000 people attended the 2012 American Association for Cancer Research (AACR) meeting, a firm fixture in the oncology calendar. The schedule for this year’s meeting, in Washington, D.C...

Pages